• Salona Global Medical Device Corporation (SGMD) has announced a bought-deal private placement for gross proceeds of $4,004,000
  • The company will issue 7,280,000 units at a price of $0.55 per unit
  • Salona has also provided the underwriters with an over-allotment option for additional gross proceeds of up to $600,600
  • The offering is expected to close on or about February 15, 2022
  • Salona Global Medical Device Corp is a U.S.-based medical device company
  • Salona Global Medical Device Corporation (SGMD) opened trading at C$0.55 per share

Salona Global Medical Device Corporation (SGMD) has announced a bought-deal private placement for gross proceeds of $4,004,000.

The company will issue 7,280,000 units at a price of $0.55 per unit. Each unit will consist of one common share and one share purchase warrant. Each warrant can be exercised for one additional share at a price of $0.70 for up to three years following the closing of the offering.

Salona has also provided the underwriters with the option to purchase up to an additional 1,092,000 units, for additional gross proceeds of up to $600,600.

Net proceeds will be used for working capital and general corporate purposes.

The offering is expected to close on or about February 15, 2022.

Salona Global Medical Device Corp is a U.S.-based medical device company. 

Salona Global Medical Device Corporation (SGMD) opened trading at C$0.55 per share.

More From The Market Online

EU authorizes new COVID vaccine from Pfizer and BioNTech

The EU grants marketing authorization to Pfizer and BioNTech's COVID-19 vaccine targeting the new XFG variant.

PharmaTher evaluating 3D printing for personalized peptide medicines

PharmaTher is out to evaluate its GMP-ready 3D printing platform for producing personalized peptide medicines with customized doses.

Why biotech is outpacing the AI slump: 3 stocks to watch

The biotech sector is outperforming the broader market, shining a light on stocks best-positioned to address unmet patient needs.

The 5-Minute Investor Podcast, Ep. 71: Weight-loss drug stocks

Listen to ep. 71 of The 5-Minute Investor Podcast, with analysis on weight-loss drug stocks Structure Therapeutics and Viking Therapeutics.